Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
C1 ESTERASE INHIBITOR 500 UNIT (10 ML) INTRAVENOUS SOLUTION (NDC 63833083501) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved October 17, 2026 , from http://ppman.hank.ai/transparency/procedure/63833083501/by-state?code_type=NDC
“C1 ESTERASE INHIBITOR 500 UNIT (10 ML) INTRAVENOUS SOLUTION (NDC 63833083501) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/63833083501/by-state?code_type=NDC. Accessed
October 17, 2026 .
“C1 ESTERASE INHIBITOR 500 UNIT (10 ML) INTRAVENOUS SOLUTION (NDC 63833083501) by State,” HANK Price Transparency ,
accessed October 17, 2026 ,
http://ppman.hank.ai/transparency/procedure/63833083501/by-state?code_type=NDC.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
NDC · across United States
63833083501 — C1 Esterase Inhibitor 500 Unit (10 Ml) Intravenous Solution
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$6,964
National median
$6,224 – $8,365
IQR (p25 – p75)
3
hospitals filing
1
states
Walking in without insurance?
Cash / self-pay price
Cash median
$8,637
vs. negotiated
+24.0%
Hospitals reporting
12
Cash / self-pay rates apply when you don't run the bill through insurance.
Many hospitals also offer income-based discounts on top of the published
cash price — always ask about a financial-assistance application
before paying.
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for 63833083501 (NDC), with interquartile range
State Median p25 p75
MI $6,964 $6,224 $8,365